Upperton Pharma Solutions
Nikki Whitfield is the Chief Executive Officer at Upperton Pharma Solutions. Prior to this role, Nikki held positions such as Vice President at Tavanta Therapeutics and Quotient Clinical Ltd. With a background in Combined Science from Nottingham Trent University, Nikki has gained extensive experience in pharmaceutical sciences and operations throughout their career at various companies including Vectura, Elan Drug Delivery, and Quadrant Drug Delivery.
This person is not in any offices
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.